Polyethylene glycol 4000 + Macrogol 3350 plus ascorbic acid
ApprovedCompleted 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Colonoscopy Preparation
Conditions
Colonoscopy Preparation
Trial Timeline
May 1, 2014 → May 1, 2016
NCT ID
NCT02073552About Polyethylene glycol 4000 + Macrogol 3350 plus ascorbic acid
Polyethylene glycol 4000 + Macrogol 3350 plus ascorbic acid is a approved stage product being developed by Rafael Holdings for Colonoscopy Preparation. The current trial status is completed. This product is registered under clinical trial identifier NCT02073552. Target conditions include Colonoscopy Preparation.
Hype Score Breakdown
Clinical
30
Activity
20
Company
2
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02073552 | Approved | Completed |
Competing Products
7 competing products in Colonoscopy Preparation
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| fospropofol disodium | Eisai | Phase 3 | 77 |
| AQUAVAN® (fospropofol disodium) Injection + Midazolam HCl | Eisai | Phase 2/3 | 65 |
| fospropofol disodium | Eisai | Phase 2 | 52 |
| fospropofol disodium | Eisai | Phase 2 | 52 |
| HSK3486 + Propofol | Haisco Pharmaceutical Group | Phase 2 | 49 |
| HSK3486 + Propofol | Haisco Pharmaceutical Group | Phase 2 | 49 |
| Methylene Blue MMX 25 mg modified release tablets | Cosmo Pharmaceuticals | Phase 2 | 47 |
Other Products from Rafael Holdings
Varenicline + Nicotine patchApproved
77
inhaled corticosteroid plus LABA plus oral corticosteroidApproved
77
IV trivalent saccharose hydroxide ferrous + Oral ferrous fumarate + Oral and intravenous PlaceboApproved
77
Insulin + insulinApproved
77
Tacrolimus with rapid steroid withdrawal + Tacrolimus with steroids minimization + CsA with steroid minimizationApproved
77